MedTrace Logo

Promoting Smoking Cessation in Lung Cancer Screening Through Proactive Treatment

NCT03612804 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 944

Last updated 2024-10-08

Study results available
· View outcomes & findings →

Summary

This pragmatic trial will evaluate the value of routinely providing proactive smoking cessation support to current smokers as a part of participating in lung cancer screening within Veterans Health Administration.

Conditions

  • Smoking Reduction
  • Tobacco Use
  • Tobacco Smoking
  • Tomography
  • Lung Diseases
  • Lung Neoplasms

Interventions

BEHAVIORAL

Unsigned note to provider about cessation medication prescription

For patients of providers assigned to the proactive study group, a local coordinator will review the patient's cessation medication history. If the patient is not currently being provided cessation support medication, the coordinator will enter a note for the provider about the recommended medication indicated by VA formulary guidelines.

BEHAVIORAL

Proactive Telephone Counseling from VA Quitline

Patients of providers assigned to the proactive study group will be contacted by specially trained counselors at the VA Quitline. Counselors will attempt to provide two sessions of proactive telephone support.

Sponsors & Collaborators

  • Fred Hutchinson Cancer Center

    collaborator OTHER

  • VA Office of Research and Development

    lead FED

Principal Investigators

  • Steven B Zeliadt, PhD MPH · VA Puget Sound Health Care System Seattle Division, Seattle, WA

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-10
Primary Completion
2023-02-09
Completion
2023-02-09

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03612804 on ClinicalTrials.gov